SCHEMBL22360709

SCHEMBL22360709

CC(=O)OC1CCC2(C)C(CCC3(C)C4CCC5(C(=O)OCc6ccccc6)CCCC5C4CCC32)C1(C)C

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18513783 0.84 NR1H2 (0.38)
SCHEMBL14049657 0.83 HSD17B10 (0.49) PTPN1
SCHEMBL12828973 0.83 HSD17B10 (0.49) PTPN1
SCHEMBL14083503 0.82 ACHE (0.49) PTPN2PTPN1
SCHEMBL19415299 0.81 F3 (0.37) PTPN1
SCHEMBL15352093 0.78 PRKCG (0.54)
SCHEMBL18798990 0.78 PRKCG (0.54)
SCHEMBL15854361 0.78 PRKCG (0.54)
SCHEMBL15854369 0.78 PRKCG (0.54)
SCHEMBL18799000 0.78 PRKCG (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3924361-B1 NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS HETERO LABS LTD (IN) 2023-09-06 EP disclosed
WO-2021161206-A1 NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS HETERO LABS LIMITED (IN) 2021-08-19 WO disclosed
WO-2020165741-A1 NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS HETERO LABS LIMITED (IN) 2020-08-20 WO disclosed